Malta - English - Medicines Authority

torrent pharma gmbh südwestpark 50, 90459 nürnberg, germany - sildenafil - film-coated tablet - sildenafil 25 mg - urologicals

Malta - English - Medicines Authority

torrent pharma gmbh südwestpark 50, 90459 nürnberg, germany - sildenafil - film-coated tablet - sildenafil 50 mg - urologicals

Malta - English - Medicines Authority

torrent pharma gmbh südwestpark 50, 90459 nürnberg, germany - sildenafil - film-coated tablet - sildenafil 100 mg - urologicals

European Union - English - EMA (European Medicines Agency)

teva b.v.  - sildenafil - erectile dysfunction - drugs used in erectile dysfunction - treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for sildenafil teva to be effective, sexual stimulation is required.,

European Union - English - EMA (European Medicines Agency)

actavis group ptc ehf - sildenafil - erectile dysfunction - urologicals - treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.in order for sildenafil actavis to be effective, sexual stimulation is required.

European Union - English - EMA (European Medicines Agency)

ratiopharm gmbh - sildenafil - erectile dysfunction - urologicals - treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for sildenafil to be effective, sexual stimulation is required.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sildenafil citrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sildenafil citrate -

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals llc - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - adults sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (pah) (world health organization [who] group i) in adults to improve exercise ability and delay clinical worsening. new dosing regimen in adults with pulmonary arterial hypertension (pah) and treatment of pah in pediatric patients (ages 1 to 17) information are approved for viatris specialty llc’s revatio (sildenafil) tablets. however, due to viatris specialty llc’s marketing exclusivity rights, this drug product is not labeled with these information. sildenafil tablets are contraindicated in patients with: - concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.1)] . - concomitant use of riociguat, a guanylate cyclase stimulator. phosphodiesterase-5 (pde-5) inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat. - known hypersensitivity to sildenafil or any component of the tablet.

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - adults sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (pah) (world health organization [who] group i) in adults to improve exercise ability and delay clinical worsening [see clinical studies (14)] . pediatric patients (1 to 17 years old) sildenafil tablets are indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (pah) (who group i) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underly improvements in exercise [see clinical studies (14)] . sildenafil tablets are contraindicated in patients with: click here to enter use in specific populations limited published data from randomized controlled trials, case-controlled trials, and case series do not report a clear association with sildenafil and major birth defects, miscarriage, or adverse maternal or fetal outcomes when sildenafil is used during pregnancy. there are risks to the mo